Dr. Lonial - ASH 2008 - A Randomized Phase I Trial of Melphalan + Bortezomib as Conditioning for Autologous Transplant for Myeloma: The Effect of Sequence of Administration
Sagar Lonial, MD Winship Cancer Institute Emory University Atlanta, Georgia U.S.A. Member, IMF Board of Scientific Advisors
12.27.08
To view the video full screen, click on the small
button next to the volume control in the
lower right hand corner.
back
button next to the volume control in the
lower right hand corner.
print
related articles